Protalix Bio (PLX) ..... Pfizer

[beatryx]

... la quiete prima della tempesta....

[beatryx]

Secondo il calendario FDA ... quasi a termine per il responso (già oggetto di precedente CRL nel febbraio us)

Cassa Ok
Fatto un primo ingresso

[beatryx]

Le ultime due conference del mese.

Protalix BioTherapeutics to Present at the Jefferies 2011 Global Healthcare Conference - Yahoo! Finance
Protalix BioTherapeutics to Present at the UBS Global Life Sciences Conference - Yahoo! Finance

info di coverage

Protalix BioTherapeutics: Near-Term Catalysts With Big Upside Potential - Seeking Alpha
Protalix Biotherapeutics: Using Plants To Treat Human Disease - Seeking Alpha


info sui financials

PLX Income Statement | Protalix BioTherapeutics, Inc. Stock - Yahoo! Finance (Profit and Loss)
PLX Balance Sheet | Protalix BioTherapeutics, Inc. Stock - Yahoo! Finance (balance sheet)

prodotto fase III
Protalix BioTherapeutics' Taliglucerase Alfa Phase III Results Published in Blood, the Journal of the American Society of Hematology - Yahoo! Finance

sentment (per quel che vale)
PLX Analyst Opinion | Protalix BioTherapeutics, Inc. Stock - Yahoo! Finance

[beatryx]

.. per l'unione delle forze

[beatryx]

up

[beatryx]

5.95

[clematiss]

6,40 up

[beatryx]

Entro venerdì vediamo i 7 ????

[beatryx]

.. ma che bel programma....


On October 26, 2011, Protalix BioTherapeutics, Inc. (the "Company") issued a press release announcing that senior management will present at four upcoming conferences:

Ernst & Young Journey 2011 Conference
Wednesday, November 2, 2011 at 2:45 PM IDT Topic: The Pfizer-Protalix Gaucher Collaboration - The Partners' Point of View Dr. David Aviezer, President & CEO
Hilton Hotel, Tel-Aviv, Israel

PDA-Parenteral Drug Association / FDA-Food and Drug Administration:
Adventitious Agents and Novel Cell Substrates Conference Thursday, November 3, 2011 at 1:15-3:15 PM ET Topic: Potential Safety and Quality Issues Related to Plants and Plant-Based Products
Dr. Yoseph Shaaltiel, Executive Vice President, R&D Hilton Washington DC / Rockville Hotel & Executive Meeting Center, Rockville,
MD, USA

Lazard Capital Markets 8th Annual Healthcare Conference Wednesday, November 16, 2011 at 1:30 PM ET Topic: Corporate Presentation
Mr. Yossi Maimon, CFO
Pierre Hotel, New York, NY, USA
A webcast of this presentation will be available at www.protalix.com on the event calendar page. A replay will be archived and available after the conference for 30 days.

World Orphan Drug Congress
Thursday, December 1, 2011 at 10:10 AM CEST Topic: Regulatory Expectations and Clinical Strategy for Treating Fabry Disease Dr. David Aviezer, President & CEO
Crowne Plaza Hotel, Geneva, Switzerland

[clematiss]

Avanti tutta

Protalix Biotherapeutics Inc (PLX.TA) Key Developments | Reuters.com